Maribavir

Maribavir
Product Description

Therapeutic Area: CMV

Status: Early

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)

More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)

  • Imidacloprid

    Product Imidacloprid

    API for Animal HealthEP
    CEP, US
  • Imipenem (+Cilastatin Sodium)

    Product Imipenem (+Cilastatin Sodium)

    Anti-infection APIIn house
    CN Status(A)
  • Ivermectin

    Product Ivermectin

    For human use: Anti-infection APIUSP, EP, CVP, IP
    USDMF, CEP, JDMF, CN Status(A)


    For animal use:
    Animal Healthcare
    USP, EP, CVP
    CEP, US/JP/CN Status
  • Letermovir

    Product Letermovir

    Anti-infection APIIn house
    CN Status(A)
  • Linezolid

    Product Linezolid

    Anti-infection APIUSP, YBY
    CN Status(A)
  • Lurasidone HCl

    Product Lurasidone HCl

    In houseUSDMF(Submitted)
    CN Status(A)
  • Mavacamten

    Product Mavacamten

    Therapeutic Area: Cardiovascular

    Status: Early

  • Micafungin Nucleus (FR179642)
  • Minocycline HCl

    Product Minocycline HCl

    Anti-infection APIUSP, CP
    USDMF, CN Status(I)
  • Mirogabalin besylate

    Product Mirogabalin besylate

    Therapeutic Area: Peripheral Neuropathic Pain

    Status: Early

  • Mycophenolic Acid

    Product Mycophenolic Acid

    Immunology APIIn house
    USDMF
  • Oclacitinib Maleate

    Product Oclacitinib Maleate

    Therapeutic Area: Pruritus & Atopic Dermatitis

    Status: Early